Filing Details
- Accession Number:
- 0000899243-19-005533
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-01 18:43:05
- Reporting Period:
- 2019-03-01
- Accepted Time:
- 2019-03-01 18:43:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1066040 | Jr E Francis Odonnell | C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-01 | 46,000 | $0.00 | 544,187 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-03-01 | 23,000 | $5.07 | 521,187 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2019-03-01 | 46,000 | $0.00 | 46,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-03-01 | No | 4 | M | Direct |
Footnotes
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of 46,000 of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 29, 2016 under the Issuer's 2011 Equity Incentive Plan, as amended.
- The shares of common stock were sold under a pre-planned 10b5-1 trading plan and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
- On March 1, 2019, the Reporting Person sold an aggregate of 23,000 shares of the Issuer's Common Stock at a weighted average price of $5.07 per share. The highest sale price for the Common Stock was $5.20 per share and the lowest sale price was $4.90 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
